{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Hereditary Breast and Ovarian Cancer: A Review of Genetic Testing and Management of High-Risk Patients

Activity Steps

1 Activity
2 Take Test 3Certificate

Description

NOTE: Individual subscribers will be required to submit payment before viewing. Users accessing via an institutional subscription can proceed without payment.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify risk of cancer in BRCA1 and BRCA2 mutation carriers
  2. Describe appropriate screening and prevention options for breast and ovarian cancer in BRCA carriers.
  3. Plan appropriate genetic testing for patients with ovarian cancer.

Disclosures

Dr. Davidson has disclosed that she was a recipient of fees from GlaxoSmithKline.

Lippincott CME Institute has identified and mitigated all relevant financial relationships regarding this educational activity.

All other authors, faculty, and staff have no relevant financial relationship with any ineligible organizations regarding this educational activity.

Price: $49.00

Credits:

  • ANCC 2.0 CH / 0.5 APH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH
  • NM - BON 2.0 CH
  • SC - BON 2.0 CH
  • WV - BOERN 2.0 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.

Awarded Advanced Pharmacology Hours













Planner
Test Code: PGO0822B
Published: Aug 2022
Expires: 8/30/2024
Sources: Topics in Obstetrics & Gynecology (Newsletter)
Required Passing Score: 7/10 (70%)
Authors: Elayna P. Kirsch, BA; Catherine Watson, MD; Jeffrey A. Kuller, MD; Brittany A. Davidson, MD; Sarah Dotters-Katz, MD, MMHPE
Categories: Advanced Pharmacology Hours , Advanced Practice Nursing , Cancer , Genetics , Gynecological , Women's Health
Specialties: Advanced Practice Nursing, Genetics, OB/GYN, Oncology, Women's Health
Topics: Breast Diseases , Cancer , Genetics , Hereditary Cancer , Ovarian Cancer